BI-1206

DB17429InvestigationalProtein Based Therapies

BI-1206 is a fully human immunoglobulin G1 monoclonal antibody that targets CD32b.

Mechanism: Pharmacologically active on Low affinity immunoglobulin gamma Fc region receptor II-b
Curator reviewed
Code names: 6G11 · BI-1206

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with BI-1206, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.